S-triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase

(19)

(11)

EP 2 135 608 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	21.03.2012 Bulletin 2012/12

(45)	Mention of the grant of the patent:
	12.10.2011 Bulletin 2011/41

(21)	Application number: 09170772.9

(22)	Date of filing: 25.08.2005

(51)

International Patent Classification (IPC):

A61K 31/4196^(2006.01)
A61P 31/18^(2006.01)

C07D 249/08^(2006.01)

(54)	S-triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase S-Triazolyl-alpha-Mercaptoacetanilide als Inhibitoren von HIV-Umkehrtranskriptase S-triazolyl alpha -mercaptoacétanilides en tant qu'inhibiteurs de la transcriptase inverse du VIH

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

25.08.2004 US 604219 P
25.08.2004 US 604220 P
31.05.2005 US 686351 P

(43)	Date of publication of application:
	23.12.2009 Bulletin 2009/52

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	05790722.2 / 1789039

(73)	Proprietor: Ardea Biosciences, Inc.
	San Diego, CA 92121 (US)

(72)	Inventors:
	Girardet, Jean-Luc Aliso Viejo, CA 92656 (US) Koh, Yung-Hyo Irvin, CA 92620 (US)

(74)	Representative: Cole, William Gwyn
	avidity IP Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ Epping, Essex CM16 5DQ (GB)

(56)

References cited: :

WO-A-2004/030611

MODI K F ET AL: "Synthesis of S-(4-aryl-4H-1,2,4-triazol-3yl) 2-mercaptomethyl benuimidazoles" JOURNAL OF THE INDIAN CHEMICAL SOCIETY, THE INDIAN CHEMICAL SOCIETY, CALCUTTA, IN, vol. 54, 1 July 1977 (1977-07-01), pages 741-742, XP009123819 ISSN: 0019-4522
MODI K F ET AL: "Synthesis of substituted arylhydrazones of 4-aryl-4H-1,2,4-triazolyl- 3-thioacetic acid hydrazides" JOURNAL OF THE INDIAN CHEMICAL SOCIETY, THE INDIAN CHEMICAL SOCIETY, CALCUTTA, IN, vol. 54, no. November, 1 November 1977 (1977-11-01), pages 1087-1089, XP009124074 ISSN: 0019-4522

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).